Jianping Hu
- Topics
- Protein Degradation and Inhibitors (3 papers)Multiple Myeloma Research and Treatments (2 papers)Cancer Immunotherapy and Biomarkers (2 papers)
- Cited by
- OncologyImmunologyHematology
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Jianping Hu
12 papers receiving 507 citations
Hit Papers
Peers
Comparison fields: 5 of 71
- Molecular Biology 243
- Oncology 198
- Immunology 122
- Epidemiology 57
- Cancer Research 55
Countries citing papers authored by Jianping Hu
This map shows the geographic impact of Jianping Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianping Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianping Hu more than expected).
Fields of papers citing papers by Jianping Hu
This network shows the impact of papers produced by Jianping Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianping Hu. The network helps show where Jianping Hu may publish in the future.
Co-authorship network of co-authors of Jianping Hu
This figure shows the co-authorship network connecting the top 25 collaborators of Jianping Hu. A scholar is included among the top collaborators of Jianping Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianping Hu. Jianping Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 6 | |
| 4 | Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillancebreakdown → | 217 |
| 5 | 2 | |
| 6 | 64 | |
| 7 | 29 | |
| 8 | 54 | |
| 9 | 3 | |
| 10 | 20 | |
| 11 | 3 | |
| 12 | 110 |
About Jianping Hu
Jianping Hu is a scholar working on Cardiology and Cardiovascular Medicine, Hematology and Oncology, having authored 12 papers that have together received 511 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (3 papers), Multiple Myeloma Research and Treatments (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Oncology (198 citations), Immunology (122 citations) and Hematology (46 citations). Jianping Hu has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Jian Jin, Hu Zhang, Xiang Chen, Hubing Shi, Yujie Zhao, Qinhe Yang, Xinyu Guo, Guiyuan Ji, Lina Guo and Zhuoqin Jiang. Their work appears in journals such as Cancer Cell, Journal of Medicinal Chemistry and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.